EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Open Access · CC BY-NC 3.0

Population Pharmacokinetic Modeling Analysis of ASC10, a Novel Antiviral Agent Targeted COVID-19, in Chinese Healthy Subjects

Duo Lv, Sichan Li, Yi Li, Meihua Lin, You Zhai iD, Meijia Wu, Yunqing Qiu iD, Qingwei Zhao, Jian Liu iD

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s517282 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Duo Lv und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Antiviral Agents, COVID-19 Drug Treatment, Models, Biological, Prodrugs. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsCOVID-19 Drug TreatmentModels, BiologicalProdrugsRibonucleosidesAdultFemaleHumansMaleMiddle AgedYoung AdultAdministration, OralChinaHealthy Volunteers

Stichwörter der Autor:innen

ASC10ASC10-ACOVID-19molnupiravirpopulation pharmacokinetics

Substanzen

Antiviral AgentsProdrugsRibonucleosides

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Zhejiang Provincial Key Laboratory for Drug Evaluation and Clinical Research, Hangzhou, People's Republic of China.
  • Department of Pharmacy, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology, Wuhan, People's Republic of China.
  • Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.

ORCID-Profile: You Zhai, Yunqing Qiu, Jian Liu

Zitieren

APA

Lv, D., Li, S., Li, Y., Lin, M., Zhai, Y., Wu, M., Qiu, Y., Zhao, Q., & Liu, J. (2025). Population Pharmacokinetic Modeling Analysis of ASC10, a Novel Antiviral Agent Targeted COVID-19, in Chinese Healthy Subjects. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s517282

Vancouver

Lv D, Li S, Li Y, Lin M, Zhai Y, Wu M, et al. Population Pharmacokinetic Modeling Analysis of ASC10, a Novel Antiviral Agent Targeted COVID-19, in Chinese Healthy Subjects. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s517282

BibTeX
@article{Lv2025,
  author = {Lv, Duo and Li, Sichan and Li, Yi and Lin, Meihua and Zhai, You and Wu, Meijia and Qiu, Yunqing and Zhao, Qingwei and Liu, Jian},
  title = {Population Pharmacokinetic Modeling Analysis of ASC10, a Novel Antiviral Agent Targeted COVID-19, in Chinese Healthy Subjects},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s517282}
}
Kostenlos starten →